CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 32166-32531 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/cb16d307afaecebd683e6d74c8b501ed54b0c9a4","sourcedb":"CORD-19","sourceid":"cb16d307afaecebd683e6d74c8b501ed54b0c9a4","text":"A cluster of pyrazolone analogues were screened and evaluated for the anti-ALS activity from FDA approved drugs and biochemical reagents by Radhia and co-workers [73] , as the most potent skeleton, the arylsulfanyl pyrazolones showed 100% efficacy compared with the positive control, radicicol (80% efficacy) in the test of G93A-SOD1 expression in PC12 cells model.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T188","span":{"begin":0,"end":365},"obj":"Sentence"},{"id":"T22422","span":{"begin":0,"end":365},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T188","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T22422","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T43","span":{"begin":75,"end":78},"obj":"Disease"},{"id":"T89079","span":{"begin":75,"end":78},"obj":"Disease"}],"attributes":[{"id":"A43","pred":"mondo_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/MONDO_0004976"},{"id":"A76397","pred":"mondo_id","subj":"T89079","obj":"http://purl.obolibrary.org/obo/MONDO_0004976"},{"subj":"T43","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T89079","pred":"source","obj":"CORD-19-PD-MONDO"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T188","span":{"begin":0,"end":365},"obj":"Sentence"}],"attributes":[{"subj":"T188","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T36","span":{"begin":75,"end":78},"obj":"Phenotype"}],"attributes":[{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0007354"},{"subj":"T36","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T9","span":{"begin":188,"end":196},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0004288"},{"subj":"T9","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ec93","default":true},{"id":"CORD-19-PD-MONDO","color":"#ec93ad"},{"id":"CORD-19_Custom_license_subset","color":"#93c8ec"},{"id":"CORD-19-PD-HP","color":"#e2ec93"},{"id":"CORD-19-PD-UBERON","color":"#dc93ec"}]}]}}